Bank of America’s Vaxart VXRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-21,776
| Closed | -$9.84K | – | 8712 |
|
|
2025
Q2 | $9.84K | Sell |
21,776
-99,865
| -82% | -$43.5K | ﹤0.01% | 7196 |
|
|
2025
Q1 | $49.5K | Sell |
121,641
-62,806
| -34% | -$40.3K | ﹤0.01% | 6751 |
|
|
2024
Q4 | $122K | Buy |
184,447
+17,942
| +11% | +$12.5K | ﹤0.01% | 6313 |
|
|
2024
Q3 | $141K | Buy |
166,505
+269
| +0.2% | +$206 | ﹤0.01% | 6188 |
|
|
2024
Q2 | $111K | Sell |
166,236
-95,555
| -37% | -$79.3K | ﹤0.01% | 6205 |
|
|
2024
Q1 | $340K | Buy |
261,791
+85,782
| +49% | +$89.9K | ﹤0.01% | 5580 |
|
|
2023
Q4 | $101K | Sell |
176,009
-11,906
| -6% | -$8.23K | ﹤0.01% | 6374 |
|
|
2023
Q3 | $142K | Sell |
187,915
-16,642
| -8% | -$12.7K | ﹤0.01% | 6088 |
|
|
2023
Q2 | $149K | Sell |
204,557
-104,619
| -34% | -$97.2K | ﹤0.01% | 6022 |
|
|
2023
Q1 | $234K | Buy |
309,176
+217,032
| +236% | +$202K | ﹤0.01% | 5835 |
|
|
2022
Q4 | $88.5K | Sell |
92,144
-849,169
| -90% | -$1.2M | ﹤0.01% | 6273 |
|
|
2022
Q3 | $2.05M | Buy |
941,313
+703,461
| +296% | +$2.43M | ﹤0.01% | 4255 |
|
|
2022
Q2 | $833K | Sell |
237,852
-394,009
| -62% | -$1.47M | ﹤0.01% | 5063 |
|
|
2022
Q1 | $3.19M | Buy |
631,861
+140,833
| +29% | +$713K | ﹤0.01% | 4106 |
|
|
2021
Q4 | $3.08M | Buy |
491,028
+414,297
| +540% | +$2.83M | ﹤0.01% | 4130 |
|
|
2021
Q3 | $610K | Sell |
76,731
-32,066
| -29% | -$264K | ﹤0.01% | 5486 |
|
|
2021
Q2 | $815K | Sell |
108,797
-77,554
| -42% | -$541K | ﹤0.01% | 5059 |
|
|
2021
Q1 | $1.13M | Buy |
186,351
+142,355
| +324% | +$1.1M | ﹤0.01% | 4729 |
|
|
2020
Q4 | $251K | Buy |
43,996
+20,948
| +91% | +$133K | ﹤0.01% | 5460 |
|
|
2020
Q3 | $153K | Sell |
23,048
-18,259
| -44% | -$163K | ﹤0.01% | 5452 |
|
|
2020
Q2 | $366K | Buy |
41,307
+4,493
| +12% | +$12.9K | ﹤0.01% | 4846 |
|
|
2020
Q1 | $66K | Buy |
36,814
+36,776
| +96,779% | +$46.8K | ﹤0.01% | 5751 |
|
|
2019
Q4 | $0 | Buy |
+38
| New | +$13 | ﹤0.01% | 7431 |
|
|
2019
Q3 | – | Sell |
-374
| Closed | – | – | 7533 |
|
|
2019
Q2 | $0 | Buy |
+374
| New | +$313 | ﹤0.01% | 7428 |
|
|
2018
Q4 | – | Sell |
-3,943
| Closed | -$11K | – | 7407 |
|
|
2018
Q3 | $11K | Buy |
+3,943
| New | +$12K | ﹤0.01% | 6656 |
|
|
2017
Q3 | – | Sell |
-6
| Closed | – | – | 7300 |
|
|
2017
Q2 | $0 | Buy |
+6
| New | +$36 | ﹤0.01% | 7193 |
|
|
2017
Q1 | – | Sell |
-27
| Closed | – | – | 7258 |
|
|
2016
Q4 | $0 | Sell |
27
-225
| -89% | -$3.44K | ﹤0.01% | 7341 |
|
|
2016
Q3 | $5K | Buy |
252
+206
| +448% | +$3.26K | ﹤0.01% | 6621 |
|
|
2016
Q2 | $1K | Buy |
46
+1
| +2% | +$17 | ﹤0.01% | 7015 |
|
|
2016
Q1 | $1K | Sell |
45
-566
| -93% | -$10.1K | ﹤0.01% | 6881 |
|
|
2015
Q4 | $13K | Buy |
611
+566
| +1,258% | +$12.4K | ﹤0.01% | 6593 |
|
|
2015
Q3 | $1K | Hold |
45
| – | – | ﹤0.01% | 7058 |
|
|
2015
Q2 | $1K | Hold |
45
| – | – | ﹤0.01% | 7148 |
|
|
2015
Q1 | $1K | Buy |
+45
| New | +$1.24K | ﹤0.01% | 6858 |
|
|
2014
Q3 | – | Sell |
-58
| Closed | -$2K | – | 8195 |
|
|
2014
Q2 | $2K | Buy |
+58
| New | +$2.42K | ﹤0.01% | 7843 |
|
|
2014
Q1 | – | Sell |
-1
| Closed | – | – | 8100 |
|
|
2013
Q4 | $0 | Sell |
1
-15
| -94% | -$660 | ﹤0.01% | 8167 |
|
|
2013
Q3 | $1K | Buy |
16
+13
| +433% | +$564 | ﹤0.01% | 7757 |
|
|
2013
Q2 | $0 | Buy |
+3
| New | +$125 | ﹤0.01% | 7769 |
|
Other funds holding VXRT
XT
HSA
BCMLT
CFO
LCM
HWA
Bank of America's VXRT Position: Q3 2025 in Review
Bank of America sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 21,776 shares — an estimated $9.84K sold.
Bank of America first reported a position in VXRT in Q2 2013 and held it in 38 quarters. The position peaked at $3.19M in Q1 2022. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.
- Bank of America reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
- Bank of America sold 21,776 Vaxart shares in Q3 2025, an estimated $9.84K.
- Bank of America first reported a position in Vaxart in Q2 2013 and held it in 38 quarters.
- Bank of America's Vaxart position peaked at $3.19M in Q1 2022.
- 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.
Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.